BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15013593)

  • 1. A novel mathematical method based on urea kinetic modeling for computing the dialysis dose.
    Prado M; Roa L; Palma A; Milán JA
    Comput Methods Programs Biomed; 2004 May; 74(2):109-28. PubMed ID: 15013593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of using 30-minute post-dialysis BUN to determine equilibrated Kt/V.
    Chirananthavat T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S54-64. PubMed ID: 17044455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.
    Marshall MR; Golper TA; Shaver MJ; Alam MG; Chatoth DK
    Am J Kidney Dis; 2002 Mar; 39(3):556-70. PubMed ID: 11877575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two methods for predicting equilibrated Kt/V (eKt/V) using true eKt/V value.
    Marsenić O; Peco-Antić A; Jovanović O
    Pediatr Nephrol; 1999 Jun; 13(5):418-22. PubMed ID: 10412862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of Kt/V evaluated using an online method and calculated from urea measurements in patients on intermittent hemodialysis.
    Grzegorzewska AE; Banachowicz W
    Hemodial Int; 2006 Oct; 10 Suppl 2():S5-9. PubMed ID: 17022752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project.
    Goldstein SL; Brem A; Warady BA; Fivush B; Frankenfield D
    Pediatr Nephrol; 2006 Aug; 21(8):1161-6. PubMed ID: 16705459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement between different parameters of dialysis dose in achieving treatment targets: results from the NECOSAD study.
    Moret KE; Grootendorst DC; Dekker FW; Boeschoten EW; Krediet RT; Houterman S; Beerenhout CH; Kooman JP;
    Nephrol Dial Transplant; 2012 Mar; 27(3):1145-52. PubMed ID: 21817058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting treatment dose for novel therapies using urea standard Kt/V.
    Leypoldt JK; Jaber BL; Zimmerman DL
    Semin Dial; 2004; 17(2):142-5. PubMed ID: 15043617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance.
    Uhlin F; Fridolin I; Magnusson M; Lindberg LG
    Nephrol Dial Transplant; 2006 Aug; 21(8):2225-31. PubMed ID: 16611681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical analysis of urea rebound in long-term hemodialysis patients.
    Ookawara S; Suzuki M; Saitou M; Tabei K
    Ther Apher Dial; 2005 Apr; 9(2):167-72. PubMed ID: 15828930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the postdialysis rebound: the reconciliation of current formulas.
    Smye SW; Tattersall JE; Will EJ
    ASAIO J; 1999; 45(6):562-7. PubMed ID: 10593687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerized urea kinetic modeling to prescribe and monitor delivered Kt/V (pKt/V, dKt/V) in peritoneal dialysis. Fresenius Randomized Dialysis Prescriptions and Clinical Outcome Study (RDP/CO).
    Gotch FA; Lipps BJ; Keen ML; Panlilio F
    Adv Perit Dial; 1996; 12():43-5. PubMed ID: 8865870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study.
    Daugirdas JT; Depner TA; Gotch FA; Greene T; Keshaviah P; Levin NW; Schulman G
    Kidney Int; 1997 Nov; 52(5):1395-405. PubMed ID: 9350665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease severity adversely affects delivery of dialysis in acute renal failure.
    Schiffl H
    Nephron Clin Pract; 2007; 107(4):c163-9. PubMed ID: 17975323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure.
    Kanagasundaram NS; Greene T; Larive AB; Daugirdas JT; Depner TA; Garcia M; Paganini EP;
    Kidney Int; 2003 Dec; 64(6):2298-310. PubMed ID: 14633155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urea modeling and Kt/V: a critical appraisal.
    Barth RH
    Kidney Int Suppl; 1993 Jun; 41():S252-60. PubMed ID: 8320932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine assessment of kidney urea clearance, dialysis dose and protein catabolic rate in the once-weekly haemodialysis regimen.
    Casino FG; Deira J; Suárez MA; Aguilar J; Basile C
    J Nephrol; 2021 Dec; 34(6):2009-2015. PubMed ID: 33891294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the different methods to predict equilibrated Kt/V in pediatric hemodialysis.
    Kietkajornkul C; Thirakhupt P; Chulamokha Y; Jaiprong S; Kitpanich S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S180-7. PubMed ID: 16858957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the hemodialysis dose.
    Leypoldt JK; Cheung AK
    Semin Dial; 2006; 19(2):96-101. PubMed ID: 16551284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic dialysance and the assessment of Kt/V: the influence of different estimates of V on method agreement.
    Moret K; Beerenhout CH; van den Wall Bake AW; Gerlag PG; van der Sande FM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2007 Aug; 22(8):2276-82. PubMed ID: 17550929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.